Dymeka Harrison serves as the Chief Commercial Officer for Foundation Medicine.
In this role, Harrison is responsible for the development and execution of the company’s global commercial strategy across all product lines. The commercial team partners throughout the oncology ecosystem to support physicians seeking personalized treatment options for their patients and closely collaborates with third-party payers to ensure appropriate diagnostic utilization. Harrison spearheads the company’s innovative customer collaborations, leading the clinical commercial team in strengthening existing customer relationships and establishing new partnerships.
Under her leadership, the team works to expand patient access to comprehensive genomic profiling and explore new opportunities to work on a systemic level with health systems, academic medical centers and community practices. With nearly two decades of experience in the diagnostics industry, Harrison joined Foundation Medicine from Abbott Laboratories, where she most recently served as Head of Strategic Marketing, overseeing global marketing efforts for the company’s Rapid Diagnostics Division.
Harrison earned her MBA from Georgia State University and has multiple B.S. degrees from North Carolina A&T State University.
